Verrica Pharmaceuticals, Inc. (VRCA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Verrica Pharmaceuticals, Inc. (VRCA)
Go deeper and ask any question about VRCA
Company Performance
Current Price
as of Sep 13, 2024$1.97
P/E Ratio
N/A
Market Cap
$84.06M
Description
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Metrics
Overview
- HQWest Chester, PA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVRCA
- Price$1.97+1.55%
Trading Information
- Market Cap$84.06M
- Float61.11%
- Average Daily Volume (1m)1,101,830
- Average Daily Volume (3m)682,254
- EPS-$1.88
Company
- Revenue$13.91M
- Rev Growth (1yr)2,744.51%
- Net Income-$17.19M
- Gross Margin89.53%
- EBITDA Margin-287.27%
- EBITDA-$14.87M
- EV$353.38M
- EV/Revenue25.41
- P/EN/A
- P/S6.59
Documents
SEC Filings
Earnings Calls
Factset Street Account